norethindrone acetate has been researched along with Thromboembolism, Venous in 3 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cockrum, RH | 1 |
| Soo, J | 1 |
| Ham, SA | 1 |
| Cohen, KS | 1 |
| Snow, SG | 1 |
| Bergendal, A | 1 |
| Kieler, H | 1 |
| Sundström, A | 1 |
| Hirschberg, AL | 1 |
| Kocoska-Maras, L | 1 |
| Casey, CL | 1 |
| Murray, CA | 1 |
1 review available for norethindrone acetate and Thromboembolism, Venous
| Article | Year |
|---|---|
HT update: spotlight on estradiol/norethindrone acetate combination therapy.
Topics: Bone Density; Breast Neoplasms; Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Drug Combinat | 2008 |
2 other studies available for norethindrone acetate and Thromboembolism, Venous
| Article | Year |
|---|---|
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
Topics: Adult; Case-Control Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medrox | 2022 |
Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estrogen Replacement Therapy; | 2016 |